Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
Bristol's Opdivo boosts kidney cancer survival beyond two years
Yahoo/Reuters
Sat, 09/26/15 - 09:54 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Novartis
Afinitor
Watch out, Afinitor. Bristol's 'breakthrough' Opdivo is coming for you
Fierce Pharma Marketing
Fri, 09/18/15 - 09:14 pm
Bristol-Myers Squibb
Afinitor
Opdivo
Novartis
kidney cancer
Bristol-Myers' Opdivo Gets Breakthrough Status for Kidney Cancer
NASDAQ.com
Wed, 09/16/15 - 09:42 am
Bristol-Myers Squibb
Opdivo
kidney cancer
breakthrough therapies
It's Official, Merck Just Caved. Who's Next?
Motley Fool
Tue, 09/8/15 - 02:05 pm
Merck
drug pricing
Keytruda
Opdivo
Bristol-Myers Squibb
Bristol-Myers' latest PD-1 win could pave the path to earlier use
Fierce Biotech
Tue, 09/8/15 - 02:03 pm
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
New data expected at lung-cancer conference on experimental drug combos
Medical Marketing and Media
Fri, 09/4/15 - 09:01 am
lung cancer
Opdivo
Yervoy
Bristol-Myers Squibb
tremelimumab
MEDI4736
AstraZeneca
Roche
atezolizumab
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Fierce Pharma Marketing
Wed, 09/2/15 - 10:16 am
Opdivo
Bristol-Myers Squibb
FDA
priority review
non-small cell lung cancer
Why the FDA Extended Review Date on Key Melanoma Drug Opdivo
24/7 Wall St
Thu, 08/13/15 - 08:43 am
melanoma
FDA
Opdivo
Bristol-Myers Squibb
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
Merck's Keytruda gains market share in Q2
Medical Marketing and Media
Wed, 07/29/15 - 10:33 am
Merck
Keytruda
anti-PD-1 immunotherapy
Opdivo
Bristol-Myers Squibb
2015’s Top 6 Big Pharma Headlines Thus Far
Motley Fool
Wed, 07/22/15 - 08:36 am
Pfizer
M&A
Hospira
AbbVie
Pharmacyclics
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Express Scripts
Bristol-Myers Squibb
Opdivo
Novartis bullish on Afinitor cancer drug despite new competition
Yahoo/Reuters
Tue, 07/21/15 - 06:52 pm
Novartis
Afinitor
Opdivo
Cometriq
Exelixis
Bristol-Myers Squibb
Bristol-Myers flags early success for PhIII Opdivo study in kidney cancer
Fierce Biotech
Mon, 07/20/15 - 09:04 am
Bristol-Myers Squibb
Opdivo
kidney cancer
How does the Keytruda-Opdivo marketing battle stack up?
Fierce Pharma Marketing
Mon, 07/13/15 - 11:05 am
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
cancer immunotherapy
Should Bristol-Myers cut payer deals to boost melanoma combo over one-drug treatments?
Fierce Pharma Marketing
Mon, 06/29/15 - 11:32 am
melanoma
Bristol-Myers Squibb
payer negotiation
Yervoy
Opdivo
Bristol-Myers' Opdivo is approved as a skin cancer treatment in Europe
Yahoo/AP
Fri, 06/19/15 - 05:44 pm
Bristol-Myers Squibb
Opdivo
Europe
skin cancer
The Biggest Selling Cancer Drugs In 2020 Show Significant Change Expected In Five Short Years
Forbes
Mon, 06/1/15 - 11:34 pm
ASCO
PDL-1 inhibitors
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
At ASCO: Bristol-Myers Rises on More Data About Cancer Drug
Barron's
Mon, 06/1/15 - 07:11 pm
ASCO
Bristol-Myers Squibb
Opdivo
ASCO 15: The top 10 setbacks, advances and head scratchers
Fierce Biotech
Mon, 06/1/15 - 12:15 pm
ASCO
Celldex Therapeutics
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Clovis Oncology
AstraZeneca
Genentech
Pairing of Two Bristol-Myers Drugs Sees Success in Battling Skin Cancer, Study Says
WSJ Online
Sun, 05/31/15 - 11:23 am
Bristol-Myers Squibb
Opdivo
Yervoy
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
next ›
last »